Results 291 to 300 of about 128,493 (313)

Sodium-glucose Co-transporter 2 Inhibitors on Body Composition in Lean Heart Failure With Preserved Ejection Fraction. [PDF]

Korean Circ J
Shimoya Y, Kagami K, Yuasa N, Tani Y, Harada T, Murakami T, Yamada E, Wada N, Ishii H, Obokata M.   +9 more
europepmc   +1 more source

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source

Flash pulmonary edema caused by paroxysmal supraventricular tachycardia in a patient with preserved ejection fraction. [PDF]

BMC Cardiovasc Disord
Deng T, Li D, Liang L, Ou B.
europepmc   +1 more source

Incident heart failure: comparing management and outcome in primary and hospital settings in Western Sweden 2008–2017

ESC Heart Failure, Volume 12, Issue 2, Page 832-838, April 2025.
Abstract Aim Heart failure (HF) is a highly prevalent condition managed in both primary care (PC) and hospital care (HC)‐based settings. HF patients managed in these two settings may differ in their demography, comorbidities and outcomes, so we aimed to compare the patient management in PC and HC in the Västra Götaland Region (VGR) in Sweden.
Xiaojing Chen, Aldina Pivodic, Maria Schaufelberger, Annika Rosengren, Michael Fu   +4 more
wiley   +1 more source

Heart Failure With Preserved Ejection Fraction: A Fascinating Journey. [PDF]

JACC Case Rep
O'Meara E.
europepmc   +1 more source

Nothing Is Wrong With My Heart: Patient-Reported Understanding of Heart Failure With Preserved Ejection Fraction. [PDF]

J Am Heart Assoc
Khodneva Y, Nordberg M, Hearld LR, Arora P, Cherrington AL.   +4 more
europepmc   +1 more source

Heart Failure with Preserved Ejection Fraction (HFpEF), Pulse Wave Velocity, and Heart Rate Recovery Interconnections-A Brief Literature Review. [PDF]

J Clin Med
Suciu BS, Turi VR, Crisan S, Luca CT, Lazar DC, Faur-Grigori AA, Petrescu M, Dache A, Cioca F, Văcărescu C, Cozma D.   +10 more
europepmc   +1 more source

Glucagon-Like Peptide-1 Receptor Agonists Versus Bariatric Surgery in Patients With Obesity and Heart Failure With Preserved Ejection Fraction. [PDF]

J Am Heart Assoc
Ibrahim R, Han W, Wang W, Kau E, Said N, Forst B, Pham HN, Abdelnabi M, Salih M, Ali NB, Farina J, Lester SJ, Lee K, Ayoub C, Arsanjani R.   +14 more
europepmc   +1 more source

Comparison of beta-blockers <i>vs</i> calcium channel blockers in heart failure with preserved ejection fraction. [PDF]

World J Cardiol
Mansoor M, Depar FN, Talha HU, Rashid HU, Ashraf A, Nouman M, Abbas M, Abbasi MT, Sher A.   +8 more
europepmc   +1 more source

Coronary microvascular disease in heart failure with preserved ejection fraction. [PDF]

Physiol Rep
Sen P, Wang L, d'Ambrosio L, Bierschenk S, Hamers J, Ornek I, Sittig T, Zhang H, Zhang J, Merkus D.   +9 more
europepmc   +1 more source